Erratum: Corrigendum: A Ruthenium Polypyridyl Intercalator Stalls DNA Replication Forks, Radiosensitizes Human Cancer Cells and Is Enhanced by Chk1 Inhibition

Scientific Reports - United Kingdom
doi 10.1038/srep39363
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells

Oncotarget
Oncology
2016English

Remodeling Collapsed DNA Replication Forks for Cancer Development

Cancer Research
Cancer ResearchOncology
2019English

CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents Against Human Breast Tumor

Journal of the Brazilian Chemical Society
Chemistry
2017English

Human NOC3 Is Essential for DNA Replication Licensing in Human Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

Inhibition of Poliovirus Replication by Prostaglandins a and J in Human Cells.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

A Model of DNA Damage Response Activation at Stalled Replication Forks by SPRTN

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Autonomous DNA Replication in Human Cells Is Affected by the Size and the Source of the DNA.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1991English

ATR and DNA-PK/CHK1 Elicit Distinct Responses in Cancer Cells

Cancer Discovery
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy